Primary Biliary Cholangitis
Showing 26 - 50 of >10,000
Chinese Primary Biliary Cholangitis on Ursodeoxycholic Acid
Recruiting
- Primary Biliary Cholangitis (PBC)
- Ursodeoxycholic Acid
-
Beijing, ChinaCentre of non-infectious liver diseases, Beijing 302 Hospital, B
Aug 27, 2021
Primary Biliary Cholangitis Trial in Canada (Emtricitabine (FTC)/Tenofovir Disoproxil (TDF), Raltegravir, Placebo Oral Capsule
Recruiting
- Primary Biliary Cholangitis
- Emtricitabine (FTC)/Tenofovir Disoproxil (TDF)
- +2 more
-
Edmonton, Alberta, Canada
- +5 more
Mar 15, 2022
TruGraf Liver Gene Expression Serial Test
Not yet recruiting
- Autoimmune Liver Disease
- +3 more
- TruGraf®
- (no location specified)
Sep 27, 2023
Biliary Cell-derived Organoids From Bile of PSC and Non-PSC
Recruiting
- Primary Sclerosing Cholangitis
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 9, 2023
Hepatitis, Autoimmune, Primary Biliary Cholangitis, Immunosuppression Trial in Chengdu (Cyclosporin A, Mycophenolate Mofetil)
Recruiting
- Hepatitis, Autoimmune
- +2 more
- Cyclosporin A
- Mycophenolate Mofetil
-
Chengdu, Sichuan, ChinaWestChina Hospital
Jun 16, 2021
Autoimmune Hepatitis, Primary Biliary Cirrhosis Trial in Chengdu (Methylprednisolone and Mycophenolate mofetil,
Recruiting
- Autoimmune Hepatitis
- Primary Biliary Cirrhosis
- Methylprednisolone and Mycophenolate mofetil
- Methylprednisolone and azathioprine
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan Univerisity
Jun 18, 2021
Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis, Cholangiocarcinoma Trial in Rochester
Recruiting
- Primary Sclerosing Cholangitis
- +3 more
-
Rochester, MinnesotaMayo Clinic
Feb 22, 2022
Primary Biliary Cholangitis Trial in United States (Bezafibrate 100 MG, Bezafibrate 200 MG, Obeticholic Acid 5 MG)
Recruiting
- Primary Biliary Cholangitis
- Bezafibrate 100 MG
- +4 more
-
Dothan, Alabama
- +25 more
Aug 24, 2022
Primary Biliary Cirrhosis Trial in Puebla (Bezafibrate 200 MG Oral Tablet, Placebo, Ursodeoxycholic Acid)
Unknown status
- Primary Biliary Cirrhosis
- Bezafibrate 200 MG Oral Tablet
- +2 more
-
Puebla, MexicoInstituto Mexicano de Seguro Social
Feb 9, 2021
Cholangiocarcinoma, Choledocholithiasis; Cholangitis, Pancreatic Cancer Trial in Mexico City (Fistulotomy - High experienced.,
Recruiting
- Cholangiocarcinoma
- +3 more
- Fistulotomy - High experienced.
- +3 more
-
Mexico City, MexicoCentro Medico Nacional Siglo XXI Hospital de Especialidades
Jul 21, 2022
Primary Biliary Cirrhosis Trial in Astana (Sublimated mare milk, Ursodeoxycholic Acid)
Completed
- Primary Biliary Cirrhosis
- Sublimated mare milk
- Ursodeoxycholic Acid
-
Astana, KazakhstanNational Research Medical Center
Jan 23, 2021
About Primary Biliary Cholangitis During January 2001 to July
Completed
- Cholangitis
- +5 more
-
Chengdu, Sichuan, ChinaWest China Hospital
Nov 7, 2020
Hepatic Decompensation and Survival Outcomes in Pediatric
Recruiting
- Cirrhosis
- +6 more
- Prediction model
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Jan 5, 2022
Primary Biliary Cholangitis Trial in Worldwide (Obeticholic acid, Bezafibrate 200 MG, OCA Placebo)
Recruiting
- Primary Biliary Cholangitis
- Obeticholic acid
- +5 more
-
Bedford Park, Perth, Australia
- +67 more
Dec 2, 2022
Bezafibrate in Patients With Primary Biliary Cholangitis (PBC)
Recruiting
- Primary Biliary Cirrhosis
- Blood sampling
- +2 more
-
Aarhus N, Region Midtjylland, Denmark
- +1 more
Nov 3, 2020
Primary Biliary Cirrhosis Trial in Aarhus N (Thiamine, Placebo)
Recruiting
- Primary Biliary Cirrhosis
- Thiamine
- Placebo
-
Aarhus N, Region Midtjylland, DenmarkDepartment of Hepatology and Gastroenterology, Aarhus University
May 19, 2021
Quantitative Magnetic Resonance Imaging in Biliary Disease:
Withdrawn
- Primary Sclerosing Cholangitis
- PSC
- Quantitative Multi parametric MRI and enhanced MRCP
- (no location specified)
Jul 14, 2021
Biliary Atresia, Cholangitis, Anti-Bacterial Agents Trial (Basic treatment: sulperazone + ursodeoxycholic acid + compound
Not yet recruiting
- Biliary Atresia
- +2 more
- Basic treatment: sulperazone + ursodeoxycholic acid + compound glycyrrhizin + methylprednisolone + vitamin AD , D , E , K + imipenem or meropenem
- Prophylactic oral antibiotics: compound sulfamethoxazole tablet (SMZ/TMP) + cefaclor
- (no location specified)
Jun 28, 2023
Primary Biliary Cirrhosis Trial in United States (Saroglitazar magnesium 2 mg, Saroglitazar magnesium 4 mg, Placebo Oral Tablet)
Completed
- Primary Biliary Cirrhosis
- Saroglitazar magnesium 2 mg
- +2 more
-
Pasadena, California
- +8 more
Jan 3, 2021
Hepatitis, Primary Biliary Cholangitis, Autoimmune Trial in Chengdu (Ursodeoxycholic acid combined with total glucosides of
Recruiting
- Hepatitis
- +2 more
- Ursodeoxycholic acid combined with total glucosides of paeony
- Ursodeoxycholic acid only
-
Chengdu, Sichuan, ChinaWest China Hospital
Mar 19, 2021
Primary Biliary Cholangitis Trial in Italy (Clinical information)
Recruiting
- Primary Biliary Cholangitis
- Clinical information
-
Ancona, Italy
- +42 more
Nov 25, 2021
Hepatitis, Autoimmune, Primary Biliary Cholangitis Trial in Chengdu (Ursodeoxycholic acid, Ursodeoxycholic acid+Low Dose
Recruiting
- Hepatitis, Autoimmune
- Primary Biliary Cholangitis
- Ursodeoxycholic acid
- Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone)
-
Chengdu, Sichuan, ChinaDivision of Gastroenterology & Hepatology,West China Hospital,Si
Mar 17, 2021
Primary Biliary Cholangitis Trial in Puerto Rico, United States (Baricitinib, Placebo)
Terminated
- Primary Biliary Cholangitis
- Baricitinib
- Placebo
-
Coronado, California
- +11 more
Sep 18, 2020
